Oncoinvent ASA (ONCIN): key financial figures for fiscal year 2025 (in NOK), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2025)
- kr 23.0M
- Net Income/Loss (FY2025)
- -kr 155.1M
- Total Assets (FY2025)
- kr 205.0M
- Total Equity (FY2025)
- kr 146.3M
- Cash Flows from Operating Activities (FY2025)
- -kr 129.9M
Source: Oncoinvent ASA annual_report filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
